Vera Therapeutics receives Investment Bank Analyst Rating Update
- ByInvesting.com-
Symbol | Exchange | Currency |
|---|
By Senad Karaahmetovic Shares of Vera Therapeutics (NASDAQ:VERA) are trading more than 50% lower in pre-market Wednesday after the company presented the results from its Phase...
After-Hours Movers: Vera Therapeutics Inc (NASDAQ:VERA) 62% LOWER; announced the Phase 2b ORIGIN clinical trial of atacicept in patients with immunoglobulin A nephropathy (IgAN)...
Vera Therapeutics, Inc. is a late-stage biotechnology company. The Company is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Its lead product candidate, atacicept, a self-administered fusion protein that blocks both B lymphocyte stimulator (BLyS) and a proliferation inducing ligand (APRIL), which stimulates B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. Atacicept is being developed for the treatment of immunoglobulin A nephropathy (IgAN), a rare autoimmune disease that can lead to dialysis, kidney transplant, serious disease, and early death. It is also developing MAU868, a monoclonal antibody that neutralizes infection with BK Virus. The Company is also planning to initiate a Phase III clinical trial of atacicept as a potential treatment for patients with LN, a severe renal manifestation of Systemic Lupus Erythematosus (SLE).
| Average | 29.14 (+233.44% Upside) |
| High | 89.00 |
| Low | 6.00 |
| Price | 8.74 |
| No. of Analysts | 7 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Buy | Sell | Strong Sell | Sell |
| Technical Indicators | Strong Buy | Strong Buy | Strong Sell | Strong Buy | Strong Sell |
| Summary | Strong Buy | Strong Buy | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 145.93 | 147.23 | 143.08 | +1.97 | +1.37% | 70.26M | NASDAQ | |||
| 177.88 | 180.68 | 161.17 | +17.61 | +10.99% | 304.01M | NASDAQ | |||
| 99.37 | 100.32 | 97.31 | +1.85 | +1.90% | 33.74M | NASDAQ | |||
| 203.65 | 206.28 | 194.05 | +5.63 | +2.84% | 54.08M | NASDAQ | |||
| 100.71 | 101.58 | 98.97 | +1.55 | +1.56% | 28.87M | NASDAQ | |||
| 102.24 | 103.49 | 99.53 | +3.02 | +3.04% | 86.77M | NASDAQ | |||
| 22.82 | 23.31 | 19.41 | +2.81 | +14.04% | 11.69M | NYSE | |||
| 7.96 | 8.14 | 7.93 | -0.23 | -2.81% | 5.98M | NYSE | |||
| 179.45 | 184.23 | 177.91 | -8.34 | -4.44% | 19.48M | NYSE | |||
| 109.02 | 109.76 | 108.34 | +0.26 | +0.24% | 6.76M | NASDAQ | |||
| 2.16 | 2.21 | 2.14 | -0.050 | -2.26% | 5.33M | NYSE | |||
| 37.95 | 38.24 | 36.44 | +1.47 | +4.03% | 21.69M | NYSE | |||
| 12.87 | 17.81 | 8.91 | +3.87 | +43.00% | 204.33M | NASDAQ | |||
| 399.37 | 410.51 | 395.29 | -29.39 | -6.85% | 2.38M | NASDAQ | |||
| 667.39 | 678.12 | 666.68 | -16.51 | -2.41% | 1.25M | NASDAQ |